| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/28/2011 | CA2778357A1 Processes for preparing a polymeric compound |
| 04/27/2011 | EP2315017A1 Method for detection of fibromyalgia |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314600A1 Myocardial peptide, preparation method and uses thereof |
| 04/27/2011 | EP2314598A1 Inhibitors of Hepatitis C virus NS3 serine protease |
| 04/27/2011 | EP2314312A2 Peptides and therapeutic application therefof |
| 04/27/2011 | EP2314311A2 Peptides and therapeutic application thereof |
| 04/27/2011 | EP2314305A2 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 04/27/2011 | EP2313426A1 Novel protease inhibitors |
| 04/27/2011 | EP2313425A2 Inorganic-binding peptides and quality control methods using them |
| 04/27/2011 | EP1987052B1 Synthesis of glucagon-like peptides |
| 04/27/2011 | EP1863849B1 Rodent pest control |
| 04/27/2011 | EP1856139B1 Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| 04/27/2011 | CN102037014A Biomarkers |
| 04/27/2011 | CN102037006A Anti-bacterial compositions |
| 04/27/2011 | CN102036676A Novel dual targeting antitumoural conjugates |
| 04/27/2011 | CN102030819A Broad spectrum polypeptin and application thereof |
| 04/27/2011 | CN102030818A Peptide inhibiting angiontensin converting enzyme |
| 04/27/2011 | CN102030817A Peptide inhibiting angiontensin converting enzyme |
| 04/26/2011 | US7932230 Antifungal paints and coatings |
| 04/26/2011 | US7932229 Peptides for treatment of tumors/cancer |
| 04/26/2011 | US7932228 Method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists |
| 04/26/2011 | US7931898 Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
| 04/26/2011 | CA2509765C Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them |
| 04/26/2011 | CA2337971C Novel anti-diabetic peptides |
| 04/26/2011 | CA2264012C Compositions and methods for polynucleotide delivery |
| 04/21/2011 | WO2011047257A1 Compositions and methods for producing cyclic peptoid libraries |
| 04/21/2011 | WO2011047190A1 Gamma amino acid building blocks |
| 04/21/2011 | WO2011047150A1 Mass spectrometry quantitation of p450 protein isoforms in hepatocytes |
| 04/21/2011 | WO2011047097A2 Inhibition of trem receptor signaling with peptide variants |
| 04/21/2011 | WO2011046309A2 A diagnostic marker for hepatocellular carcinoma comprising anti-fasn autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof |
| 04/21/2011 | WO2010144231A3 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 04/21/2011 | WO2010117997A3 Peptide targeting of inner ear cells |
| 04/21/2011 | WO2010115080A3 Self-assembling peptides bearing organic electronic functionality and applications employing the same |
| 04/21/2011 | US20110092673 Isolated Antibodies Against Biologically Active Leptin-Related Peptides |
| 04/21/2011 | US20110092672 Nanoparticle and magnetic resonance imaging contrast agent |
| 04/21/2011 | US20110092671 Peptide manufacturing process |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092448 Peptide Conjugate for Oral Delivery of Hydrophilic Peptide Analgesics |
| 04/21/2011 | US20110092446 Compositions and methods for treatment of trauma |
| 04/21/2011 | US20110092437 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 04/21/2011 | US20110092434 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
| 04/21/2011 | US20110092431 Skin aging-inhibiting peptide |
| 04/21/2011 | US20110092427 Polypeptide and pharmaceutical composition containing the polypeptide |
| 04/21/2011 | US20110092418 Chimeric Relaxin Polypeptides Comprising an A and B Chain Derived From Different Relaxin Family Peptides |
| 04/21/2011 | US20110092386 Isolating biological modulators from biodiverse gene fragment libraries |
| 04/21/2011 | US20110092384 Compositions and methods for producing coded peptoid libraries |
| 04/21/2011 | US20110091981 Mass Spectrometry Quantitation of P450 Isoforms in Hepatocytes |
| 04/21/2011 | US20110091530 Oligopeptide tyrosinase inhibitors and uses thereof |
| 04/21/2011 | US20110091489 Survivin peptide vaccine |
| 04/21/2011 | US20110091467 Compositions and methods for modulating dopamine neurotransmission |
| 04/21/2011 | US20110091458 Anti-il 13 human antibodies |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091398 Oleanoyl peptide composition and a method of treating skin aging |
| 04/21/2011 | CA2777700A1 Improved peptidomimetic macrocycles |
| 04/21/2011 | CA2777690A1 Mass spectrometry quantitation of p450 protein isoforms in hepatocytes |
| 04/20/2011 | EP2312318A1 Prion protein ligands and methods of use |
| 04/20/2011 | EP2311852A1 Anti-infarction molecules |
| 04/20/2011 | EP2311851A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/20/2011 | EP2311849A1 Specific binding agents of human angiopoietin-2 |
| 04/20/2011 | EP2311480A1 Compstatin analogs with improved activity |
| 04/20/2011 | EP2311479A1 Compstatin analogs with improved activity |
| 04/20/2011 | EP2310861A1 Healthy kidney biomarkers |
| 04/20/2011 | EP2310405A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 04/20/2011 | EP2310033A2 Compounds for treating amyloidoses |
| 04/20/2011 | CN1849395B HLA-a24 binding cancer antigen peptide derived from ribin |
| 04/20/2011 | CN1643148B Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same |
| 04/20/2011 | CN102026667A Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 04/20/2011 | CN102023219A Composition for detecting rheumatoid arthritis immune antibody by colloidal gold lateral chromatography |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102020704A Methods and compositions for the treatment of gastrointestinal disorders |
| 04/20/2011 | CN102020703A Method for preparing fatty acyl cyclic depsipeptide compounds by solid-phase synthesis |
| 04/20/2011 | CN102020702A Influenza A type H3N2 virus hemagglutinin protein affinity peptide |
| 04/20/2011 | CN102020701A Hemagglutinin protein affinity peptide of influenza A H1N1 virus |
| 04/20/2011 | CN102020700A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/20/2011 | CN101418047B Antigen-antibody compound crystal and preparation method thereof and antigen epitope |
| 04/20/2011 | CN101412747B Novel cell-penetrating peptide and uses thereof |
| 04/20/2011 | CN101318995B Substituted tetrahydro-isoquinoline isoquinolinium compound, preparation method and application thereof |
| 04/19/2011 | US7928188 Antigen polypeptide for the diagnosis and/or treatment of ovarian cancer |
| 04/19/2011 | US7928186 Cell permeable bioactive peptide conjugates |
| 04/19/2011 | US7928075 Binding agents which inhibit myostatin |
| 04/19/2011 | US7928057 Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use |
| 04/19/2011 | US7927811 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 04/19/2011 | US7927581 Peptide-based multimeric targeted contrast agents |
| 04/19/2011 | CA2515322C Leukocyte stimulating peptides |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/19/2011 | CA2425271C Liposomes encapsulating anticancerous drugs and use thereof in the treatment of malignant tumours |
| 04/19/2011 | CA2399187C Kahalalide compounds |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2362496C Polypeptide variants with increased heparin-binding ability |
| 04/19/2011 | CA2320962C Novel mixed amylin activity compounds |
| 04/19/2011 | CA2320429C Antimicrobial peptides and derived metapeptides |
| 04/19/2011 | CA2291963C Tumor necrosis factor receptor-derived peptide analogues |
| 04/14/2011 | WO2011044374A1 Capcna peptide therapeutics for cancer |
| 04/14/2011 | WO2011020596A3 Cyclosporine derivatives |
| 04/14/2011 | WO2010038027A9 Immunogenic peptides and uses thereof |
| 04/14/2011 | US20110087005 Hla-binding peptide, precursor thereof, and dna fragment and recombinant vector coding for said hla-binding peptide |
| 04/14/2011 | US20110087004 Enhanced oral transcompartmental delivery of therapeutic or diagnostic agents |
| 04/14/2011 | US20110086808 Modified therapeutic agents |